-
Spinraza improves motor and respiratory function in children with SMA
Spinraza was developed by Biogen and is the only approved treatment for all types of SMA in several countries. These countries include the U.S., the European Union, Brazil, Japan, Switzerland, Australia, South Korea, Canada and Chile.
This treatment has been shown to improve motor and respiratory function in children with spinal muscular atrophy.
Read more about it here: Spinraza Improves Motor and Respiratory Function in SMA Children, Trials Show
This is promising news! Are you, or anyone you know, being treated with Spinraza?
-
0 Replies
Sorry, there were no replies found.
Log in to reply.